Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates (Q79252224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J García-Guerrero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

P Sáiz de la Hoya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

A Marco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J Sánchez-Payá

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

S Moreno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Estudio de Resistencias en Prisiones Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

695-701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17043836%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure

20 December 2019

cites work

1 reference

12 December 2020

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

1 reference

12 December 2020

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain

1 reference

12 December 2020

Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy

1 reference

12 December 2020

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

1 reference

12 December 2020

Differential Characteristics of AIDS Patients with a History of Imprisonment

1 reference

12 December 2020

Drug resistance mutations in HIV-1.

1 reference

12 December 2020

Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy

1 reference

12 December 2020

Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.

1 reference

12 December 2020

High rate of resistance to antiretroviral drugs among HIV-infected prison inmates

1 reference

12 December 2020

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

1 reference

12 December 2020

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

12 December 2020

[Primary HIV drug resistance in a prison population. REPRICOVA-2 Study]

1 reference

12 December 2020

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

1 reference

12 December 2020

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

12 December 2020

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers]

1 reference

12 December 2020

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

12 December 2020

Mutations of resistance of HIV-1 in previously untreated patients at penitentiary centers of the Autonomous Community of Valencia, Spain. REPRICOVA study

1 reference

12 December 2020

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

12 December 2020

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

1 reference

12 December 2020

[GESIDA Consensus document on the use of resistance studies in clinical practice]

1 reference

12 December 2020